Xtandi
Term · Oncology and biomedicine · MLC-T-ONC-009427
A drug used to treat certain types of prostate cancer. It is also being studied in the treatment of other types of cancer. Xtandi binds to proteins called androgen receptors, which are found in some prostate cancer cells. These proteins bind to androgens (male hormones) and may cause cancer cells to grow. Xtandi blocks these proteins and may keep cancer cells from growing. It is a type of antiandrogen. Also called enzalutamide.
| Identifier | MLC-T-ONC-009427 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | enzalutamide |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009427",
"term": "Xtandi",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat certain types of prostate cancer. It is also being studied in the treatment of other types of cancer. Xtandi binds to proteins called androgen receptors, which are found in some prostate cancer cells. These proteins bind to androgens (male hormones) and may cause cancer cells to grow. Xtandi blocks these proteins and may keep cancer cells from growing. It is a type of antiandrogen. Also called enzalutamide.",
"synonyms": [
"enzalutamide"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/xtandi/"
}
Record 17,523 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.